Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Colorectal cancer Colibactin and lipids
Rituximab
Biomarker
Colon cancer
Microbiote
Vedolizumab
Over 80s
Bactéries
Gènes
Crohn's disease
HIV
PCR
Intestinal crypts
Ustekinumab
MARKER
Original Article Clinical
Epigénétiques
Stricture
Gene expression
Endoscopic treatment
DNA METHYLATION
MORTALITY
RISK
Contraindication
Disability
Biologics
Résistance
Inclusion
DNA methylation
Immune cells
Drug
Effectiveness
Small molecules
Ulcerative colitis
Dysbiose
Méthylation
Neoadjuvant chemotherapy
Tailored therapy
Safety
Patient-reported outcome
Disease Progression
IBD
Screening
Algorithm
Bacteria
Eligibility
Primary sclerosing cholangitis
Surgery
Genes
Anti-TNF
Heart disease risk factors
Monitoring
Cell adhesion
MALT
Inflammatory bowel diseases
Rituximab plus chlorambucil
Consensus
Patients experience
Alkylating agents
Parvimonas micra
Epigenetics
Cancer
Acceptability
Inflammatory bowel disease
Survival
Maintenance therapy
Kidney diseases
Clinical guidelines
18 FDG-PET/CT
Colorectal cancer
Tuberculosis
Helicobacter pylori
Colon
IL12
T1118 translocation
Upper gastrointestinal tract
Eradication
Therapeutics
Gene methylation
MICROBIOTA
IL23
Resistance
Microbiota
Cost effectiveness
Colectomy
COLON-CANCER
Fecal microbiota
Methylation
Anti-TNF agents
Crohn’s disease
Disease progression
CARCINOGENESIS
Immunosuppressant
Thérapie ciblée
Dysbiosis
Inflammatory Bowel Diseases
Colonic epithelial primary cells
Venous thromboembolism
Inhibitor
Clinical trial
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|